AGS MEDICAL LTD

🌳Matureactive
09513683 · ltd · incorporated 2015-03-27
Investment thesis
Well-run mature business — low negotiation leverage; premium likely.
Why interesting: Textbook target; clean filings, stable trading.
Why risky: No pressure on seller; any deal likely at full price.
Opportunity decay
hardening · 12-months
Already tight — no obvious softening catalysts on the horizon.
  • · Thesis: well-run, low negotiation leverage
🔒Estimated value
Upgrade to see
Turnover
year to Mar 2025
Net worth
£132.5k
book net assets
Opportunity
79/100
Strong
🔔
Follow this company (free)
Email alerts on filings, charges, director changes, gazette notices. No account needed.

Unsubscribe any time from any email. GDPR-respectful.

What this business does
Primary activity: General medical practice activities
Sector: Human health & social work
Investor take
Pursue
Asset-holding vehicle with a 68-year-old founder — textbook succession opportunity.

Opportunity 79/100 (strong), bankability 75/100. Strong seller-intent signal (68/100, director aged 68). Share purchase looks the cleaner deal structure. Most likely exit: share sale to pe / searcher (73/100).

Data confidence

Overall: medium (78/100)

Adequate coverage. AI outputs are reliable for the sections scored high; verify the rest in diligence.

Company profile
address, 1 SIC codes, incorporation date
100
Financials
2 years of iXBRL accounts extracted (YoY deltas available) + narrative notes parsed
75
Lenders & charges
Confirmed no charges registered
85
Directors & officers
3 officers (2 active, 3 linked, 3 with DOB)
90
Ownership & PSC
1 active PSC(s) of 3 total, 3 with control declared
90
Director network
Network not yet resolved
30
Filing history
42 filings on record
85
Gazette notices
No matching gazette notices (standard for active companies)
60
Opportunity Score
79/100Strong
PassWatchWorth a lookStrongExceptional 

Solid opportunity signal. Worth a dedicated memo and management meeting.

Business quality
70
Active, clean filings, stable charge profile.
Acquirability
75
Strong succession / seller-readiness signals.
Risk profile
85
Few red flags.
Signal strength
90
Good data coverage for analysis.

Signals from accounts

Derived from iXBRL accounts · FRS 105 (micro)
Positive net assets
Net assets £132,477

Key financials

2 years extracted from filed iXBRL accounts
Cash
Net Worth
£132k
↑ 5.9% YoY
Current Assets
£82k
↓ 56% YoY
Current Liabilities
£0£37k£74k£111k£148k£185kMar 2024Mar 2025

Hover to see exact values · click legend to toggle series

Financials

Extracted from Companies House accounts · FRS 105 (micro)
Metric2025-03-312024-03-31
Total assets£132.5k£125.1k
Current assets£81.7k£185.4k
Cash£184.7k
Debtors£740
Net assets£132.5k£125.1k

Amounts extracted automatically from iXBRL. Fields left blank were not reported or not mapped. Values in GBP unless stated.

🔒Filing-note intelligence

1 signal detected in this company's narrative notes — going-concern language, audit opinion, contingent liabilities, related-party transactions.

Available from the Pro tier upwards.

See pricing →

Recent activity

Last 30 days
0
filings
Last 90 days
1
filing
  • 1 confirmation-statement
Last 180 days
1
filing
  • 1 confirmation-statement
Counts from Companies House filing history.
Corporate timeline (23 events)Click to expand
  1. 2025-12-09
    📄
    accounts-with-accounts-type-micro-entity
    accounts · AA
  2. 2025-03-27
    📄
    cessation-of-a-person-with-significant-control
    persons-with-significant-control · PSC07
  3. 2025-03-27
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  4. 2025-01-07
    📄
    change-person-director-company-with-change-date
    officers · CH01
  5. 2025-01-07
    📄
    change-person-director-company-with-change-date
    officers · CH01
  6. 2025-01-07
    📍
    change-registered-office-address-company-with-date-old-address-new-address
    address · AD01
  7. 2025-01-07
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  8. 2025-01-07
    📄
    notification-of-a-person-with-significant-control
    persons-with-significant-control · PSC01
  9. 2025-01-07
    📄
    cessation-of-a-person-with-significant-control
    persons-with-significant-control · PSC07
  10. 2024-12-03
    📄
    accounts-with-accounts-type-unaudited-abridged
    accounts · AA
  11. 2024-01-02
    SYED, Anahita resigned
    director
  12. 2024-01-02
    📄
    termination-director-company-with-name-termination-date
    officers · TM01
  13. 2023-12-15
    📄
    accounts-with-accounts-type-unaudited-abridged
    accounts · AA
  14. 2022-12-07
    📄
    accounts-with-accounts-type-unaudited-abridged
    accounts · AA
  15. 2021-10-26
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  16. 2020-10-15
    📄
    accounts-with-accounts-type-total-exemption-full
    accounts · AA
  17. 2020-01-07
    📄
    change-to-a-person-with-significant-control
    persons-with-significant-control · PSC04
  18. 2020-01-07
    📄
    change-person-director-company-with-change-date
    officers · CH01
  19. 2019-12-20
    📄
    accounts-with-accounts-type-unaudited-abridged
    accounts · AA
  20. 2018-11-08
    SYED, Gibran appointed
    director
  21. 2015-03-27
    🏢
    Company incorporated
    As AGS MEDICAL LTD
  22. 2015-03-27
    AMJAD, Syed, Dr appointed
    director
  23. 2015-03-27
    SYED, Anahita appointed
    director

Owner dependency

73/100
High — earn-out structure required

Material founder dependency. Consider a 2-3 year earn-out and build in a handover plan before completion.

FACTORS
  • +Two-director setup: Only two active directors — typical of owner-managed SMEs but limits succession.
  • +Founder age: Director aged approximately 68 — succession pressure is live.

Succession & seller-readiness

61/100
Strong succession signal

Multiple signals suggest succession is on the horizon. Candidate for proactive outreach.

SIGNALS
  • primaryFounder aged 63+: Senior director is approximately 68. Approaching typical UK retirement age — succession thinking likely.
  • secondaryTwo-director governance: Small-team governance. Succession depth is thin but not absent.
  • supportingClean filings + long tenure: Disciplined long-tenure operator — classic lifestyle-business pattern that often sells quietly.

Red flags

clean
No red flags detected from available public data. (This is not a clean bill of health — detailed accounts review still recommended.)

Shareholders & ownership

1 active beneficial owner · dominant holder ≥75%
NameSharesVoting rightsNature of controlNotified
Mr Gibran Syed
Individual · Irish · DOB 02/1999 · age 27
75100%
75–100%75-100% shares · 75-100% voting27/03/2017
2 historic (ceased) PSCs
  • Dr Syed Amjadceased 11/03/2025· 50-75% shares · 50-75% voting · board control
  • Miss Anahita Syedceased 01/05/2024· 25-50% shares

From Companies House Persons with Significant Control filings. Share ranges are banded per the public PSC regime.

Similar companies

Active · Healthcare & medical · LL postcode area
CompanyEst. valueTurnoverNet worthStaffAgeOppDirector
2SK CARE HOMES LTD
10842062 · est 2017 · no financials extracted
8y
A KHALIFA LIMITED
14400307 · est 2022 · no financials extracted
3y
ABDO LIMITED LIMITED
15900285 · est 2024 · no financials extracted
1y
ABUGUMAH LIMITED
16222697 · est 2025 · no financials extracted
1y
ACTIVITIES FOR YOU C.I.C.
14286840 · est 2022 · no financials extracted
3y
ADFERIAD RECOVERY LIMITED
02751104 · est 1992 · no financials extracted
33y
ADHD LAB UK LTD
17100120 · est 2026 · no financials extracted
AGATA WILLIAMS LIMITED
14824256 · est 2023 · no financials extracted
2y
AGE CYMRU GWYNEDD A MON
07621068 · est 2011 · no financials extracted
14y
AGE CYMRU NORTH TRADING LTD
08694568 · est 2013 · no financials extracted
12y
AINGARTH REST HOME LIMITED
08667052 · est 2013 · no financials extracted
12y
AINSLEY CLINIC LIMITED
09212487 · est 2014 · no financials extracted
11y
Peers ranked by estimated value, then turnover, then opportunity score.See all →
🔒Tailored diligence questions

7 specific questions generated from this company's actual signals — liquidity, leverage, director age, charge count, red flags, age-of-company.

Available from the Pro tier upwards.

See pricing →
🔒Advanced scoring suite

Exit-route ranking, improvement thesis, quiet-distress detector, covenant-pressure proxy, extraction monitor, approaching triggers, ownership drift, local cluster, value trap, debt capacity, archetype classification — 48+ scoring modules.

Available from the Pro tier upwards.

See pricing →

Company details

Statusactive
Typeltd
Incorporated2015-03-27
Jurisdictionengland-wales
Primary SIC86210 — General medical practice activities

Registered office

41 Trem Elidir
Bangor
LL57 2UF
Wales

Filing status

Accounts
Next due: 2026-12-31
Last made up to: 2025-03-31
Confirmation statement
Next due: 2027-04-10
Last: 2026-03-27

Officers (2 active · 1 resigned)

AMJAD, Syed, Dr
director · ~68y · appointed 2015-03-27
View their other companies + combined net worth →
Active
SYED, Gibran
director · ~27y · appointed 2018-11-08
View their other companies + combined net worth →
Active
SYED, Anahita
director · ~38y · appointed 2015-03-27 · resigned 2024-01-02
Resigned

Click a director name to see their full track record across all companies.

Recent filings (42 total)

confirmation-statement-with-no-updates
confirmation-statement · CS01
2026-04-13
accounts-with-accounts-type-micro-entity
accounts · AA
2025-12-09
cessation-of-a-person-with-significant-control
persons-with-significant-control · PSC07
2025-03-27
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2025-03-27
confirmation-statement-with-updates
confirmation-statement · CS01
2025-03-27
change-person-director-company-with-change-date
officers · CH01
2025-01-07
change-person-director-company-with-change-date
officers · CH01
2025-01-07
change-registered-office-address-company-with-date-old-address-new-address
address · AD01
2025-01-07
change-to-a-person-with-significant-control
persons-with-significant-control · PSC04
2025-01-07
notification-of-a-person-with-significant-control
persons-with-significant-control · PSC01
2025-01-07
cessation-of-a-person-with-significant-control
persons-with-significant-control · PSC07
2025-01-07
accounts-with-accounts-type-unaudited-abridged
accounts · AA
2024-12-03
confirmation-statement-with-updates
confirmation-statement · CS01
2024-03-27
termination-director-company-with-name-termination-date
officers · TM01
2024-01-02
accounts-with-accounts-type-unaudited-abridged
accounts · AA
2023-12-15